Independent Validation of Effect of HSD3B1 Genotype on Response to Androgen-Deprivation Therapy in Prostate Cancer.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 28208175.
- Also identified by DOI 10.1001/jamaoncol.2017.0147 and PMC identifier 5824318.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Using data from a prostate cancer registry, this study correlated <i>HSD3B1</i> genotype with response to androgen-deprivation therapy in patients with prostate cancer.
Medical subject headings
- Androgen Antagonists
- Germ-Line Mutation
- Multienzyme Complexes
- Progesterone Reductase
- Prostatic Neoplasms
- Steroid Isomerases